Healthcare technology company that develops software to accelerate cancer research and improve patient care through real-world evidence.
Flatiron Health is a healthcare technology company focused on accelerating cancer research and improving patient care. Founded in 2012, the company develops software solutions that capture and structure real-world clinical data from cancer patients to generate evidence for researchers, regulators, and pharmaceutical companies. Flatiron's platform aggregates data from electronic health records across oncology practices to create comprehensive datasets for clinical research. The company was acquired by Roche in 2018 for $1.9 billion, recognizing its significant role in transforming oncology research through technology-enabled real-world evidence.
Flatiron Health has received investment from 10 venture capital firms.
| Date | Round | Amount | Lead Investor |
|---|---|---|---|
| Sep 2025 | Growth | $250M | Wellington Management Ventures |
Healthcare technology company that develops software to accelerate cancer research and improve patient care through real-world evidence.
Flatiron Health has received investment from 7wire Ventures, Ascension Ventures, F-Prime Capital, F-Prime Capital (fka Fidelity Biosciences), First Round Capital and 5 other investors. These venture capital firms and investors provide both capital and strategic support.
Flatiron Health has raised $313M in total funding, with their most recent round being a Series B. The company operates in the Digital Health sector.
Flatiron Health was founded in 2012 and is headquartered in New York, New York.
Flatiron Health operates in the Digital Health sector. Healthcare technology company that develops software to accelerate cancer research and improve patient care through real-world evidence.
